Metsera accepts Pfizer's $10 billion bid in ongoing M&A battle
By Rishabh Jaiswal and Sabrina Valle (Reuters) -Obesity drug developer Metsera said on Friday that it accepted Pfizer's $10 billion acquisition offer, in what could be the end of a bidding war between the New York-based pharma giant and rival Novo Nordisk...
Reuters